Fluoxetine induces cytotoxic endoplasmic reticulum stress and autophagy in triple negative breast cancer

World Journal of Clinical Oncology

Volumn 6, Issue 6, 2015, Pages 299-311

  Bowie, Michelle ^a   Pilie, Patrick ^b   Wulfkuhle, Julia ^c   Lem, Siya ^a   Hoffman, Abigail ^a   Desai, Shraddha ^a   Petricoin, Emanuel ^c   Carter, Amira ^a   Ambrose, Adrian ^a   Seewaldt, Victoria ^a   Yu, Dihua ^d   Drendall, Catherine Ibarra ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c GEORGE MASON UNIVERSITY   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Apoptosis; Autophagy; Endoplasmic reticulum stress; Fluoxetine; Inflammatory breast cancer

Indexed keywords

EID: 84951953660     PISSN: None     EISSN: 22184333     Source Type: Journal    
DOI: 10.5306/wjco.v6.i6.299     Document Type: Review

References (49)

1. Prat A, Adamo B, Cheang MC, Anders CK, Carey LA, Perou CM. Molecular characterization of basal-like and non-basal-like triplenegative breast cancer. Oncologist 2013; 18: 123-133 [PMID: 23404817 DOI: 10.1634/theoncologist.2012-0397]
2. Yang ZJ, Chee CE, Huang S, Sinicrope FA. The role of autophagy in cancer: therapeutic implications. Mol Cancer Ther 2011; 10: 1533-1541 [PMID: 21878654 DOI: 10.1158/1535-7163. MCT-11-0047]
3. Cloonan SM, Williams DC. The antidepressants maprotiline and fluoxetine induce Type II autophagic cell death in drug-resistant Burkitt's lymphoma. Int J Cancer 2011; 128: 1712-1723 [PMID: 20503272 DOI: 10.1002/ijc.25477]
4. Shao Y, Gao Z, Marks PA, Jiang X. Apoptotic and autophagic cell death induced by histone deacetylase inhibitors. Proc Natl Acad Sci USA 2004; 101: 18030-18035 [PMID: 15596714]
5. Kanzawa T, Zhang L, Xiao L, Germano IM, Kondo Y, Kondo S. Arsenic trioxide induces autophagic cell death in malignant glioma cells by upregulation of mitochondrial cell death protein BNIP3. Oncogene 2005; 24: 980-991 [PMID: 15592527 DOI: 10.1038/ sj.onc.1208095]
6. Turcotte S, Chan DA, Sutphin PD, Hay MP, Denny WA, Giaccia AJ. A molecule targeting VHL-deficient renal cell carcinoma that induces autophagy. Cancer Cell 2008; 14: 90-102 [PMID: 18598947 DOI: 10.1016/j.ccr.2008.06.004]
7. Clarke R, Cook KL, Hu R, Facey CO, Tavassoly I, Schwartz JL, Baumann WT, Tyson JJ, Xuan J, Wang Y, Wärri A, Shajahan AN. Endoplasmic reticulum stress, the unfolded protein response, autophagy, and the integrated regulation of breast cancer cell fate. Cancer Res 2012; 72: 1321-1331 [PMID: 22422988 DOI: 10.1158/0008-5472.CAN-11-3213]
8. Tam AB, Mercado EL, Hoffmann A, Niwa M. ER stress activates NF-κB by integrating functions of basal IKK activity, IRE1 and PERK. PLoS One 2012; 7: e45078 [PMID: 23110043 DOI: 10.1371/journal.pone.0045078]
9. Benbrook DM, Long A. Integration of autophagy, proteasomal degradation, unfolded protein response and apoptosis. Exp Oncol 2012; 34: 286-297 [PMID: 23070014]
10. Li J, Ni M, Lee B, Barron E, Hinton DR, Lee AS. The unfolded protein response regulator GRP78/BiP is required for endoplasmic reticulum integrity and stress-induced autophagy in mammalian cells. Cell Death Differ 2008; 15: 1460-1471 [PMID: 18551133 DOI: 10.1038/cdd.2008.81]
11. Bertolotti A, Zhang Y, Hendershot LM, Harding HP, Ron D. Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response. Nat Cell Biol 2000; 2: 326-332 [PMID: 10854322 DOI: 10.1038/35014014]
12. Ogata M, Hino S, Saito A, Morikawa K, Kondo S, Kanemoto S, Murakami T, Taniguchi M, Tanii I, Yoshinaga K, Shiosaka S, Hammarback JA, Urano F, Imaizumi K. Autophagy is activated for cell survival after endoplasmic reticulum stress. Mol Cell Biol 2006; 26: 9220-9231 [PMID: 17030611 DOI: 10.1128/ MCB.01453-06]
13. Isbister GK, Bowe SJ, Dawson A, Whyte IM. Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose. J Toxicol Clin Toxicol 2004; 42: 277-285 [PMID: 15362595]
14. Wong DT, Bymaster FP, Engleman EA. Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: twenty years since its first publication. Life Sci 1995; 57: 411-441 [PMID: 7623609]
15. Brandes LJ, Arron RJ, Bogdanovic RP, Tong J, Zaborniak CL, Hogg GR, Warrington RC, Fang W, LaBella FS. Stimulation of malignant growth in rodents by antidepressant drugs at clinically relevant doses. Cancer Res 1992; 52: 3796-3800 [PMID: 1617649]
16. Coogan PF, Palmer JR, Strom BL, Rosenberg L. Use of selective serotonin reuptake inhibitors and the risk of breast cancer. Am J Epidemiol 2005; 162: 835-838 [PMID: 16177141 DOI: 10.1093/ aje/kwi301]
17. Wernli KJ, Hampton JM, Trentham-Dietz A, Newcomb PA. Antidepressant medication use and breast cancer risk. Pharmacoepidemiol Drug Saf 2009; 18: 284-290 [PMID: 19226540 DOI: 10.1002/pds.1719]
18. Abdul M, Logothetis CJ, Hoosein NM. Growth-inhibitory effects of serotonin uptake inhibitors on human prostate carcinoma cell lines. J Urol 1995; 154: 247-250 [PMID: 7776439 DOI: 10.1016/ S0022-5347(01)67288-4]
19. Arimochi H, Morita K. Characterization of cytotoxic actions of tricyclic antidepressants on human HT29 colon carcinoma cells. Eur J Pharmacol 2006; 541: 17-23 [PMID: 16753142 DOI: 10.1016/j.ejphar.2006.04.053]
20. Stepulak A, Rzeski W, Sifringer M, Brocke K, Gratopp A, Kupisz K, Turski L, Ikonomidou C. Fluoxetine inhibits the extracellular signal regulated kinase pathway and suppresses growth of cancer cells. Cancer Biol Ther 2008; 7: 1685-1693 [PMID: 18836303 DOI: 10.4161/cbt.7.10.6664]
21. Lee CS, Kim YJ, Jang ER, Kim W, Myung SC. Fluoxetine induces apoptosis in ovarian carcinoma cell line OVCAR-3 through reactive oxygen species-dependent activation of nuclear factorkappaB. Basic Clin Pharmacol Toxicol 2010; 106: 446-453 [PMID: 20050848 DOI: 10.1111/j.1742-7843.2009.00509.x]
22. Krishnan A, Hariharan R, Nair SA, Pillai MR. Fluoxetine mediates G0/G1 arrest by inducing functional inhibition of cyclin dependent kinase subunit (CKS)1. Biochem Pharmacol 2008; 75: 1924-1934 [PMID: 18371935 DOI: 10.1016/j.bcp.2008.02.013]
23. Zhou T, Duan J, Wang Y, Chen X, Zhou G, Wang R, Fu L, Xu F. Fluoxetine synergys with anticancer drugs to overcome multidrug resistance in breast cancer cells. Tumour Biol 2012; 33: 1299-1306 [PMID: 22549660 DOI: 10.1007/s13277-012-0377-4]
24. Levkovitz Y, Gil-Ad I, Zeldich E, Dayag M, Weizman A. Differential induction of apoptosis by antidepressants in glioma and neuroblastoma cell lines: evidence for p-c-Jun, cytochrome c, and caspase-3 involvement. J Mol Neurosci 2005; 27: 29-42 [PMID: 16055945 DOI: 10.1385/JMN:27:1:029]
25. Seewaldt VL, Johnson BS, Parker MB, Collins SJ, Swisshelm K. Expression of retinoic acid receptor beta mediates retinoic acidinduced growth arrest and apoptosis in breast cancer cells. Cell Growth Differ 1995; 6: 1077-1088 [PMID: 8519684]
26. D'Amato NC, Ostrander JH, Bowie ML, Sistrunk C, Borowsky A, Cardiff RD, Bell K, Young LJ, Simin K, Bachelder RE, Delrow J, Dawson A, Yee LD, Mrózek K, Clay TM, Osada T, Seewaldt VL. Evidence for phenotypic plasticity in aggressive triple-negative breast cancer: human biology is recapitulated by a novel model system. PLoS One 2012; 7: e45684 [PMID: 23049838 DOI: 10.1371/journal.pone.0045684]
27. Espina V, Liotta LA, Petricoin EF. Reverse-phase protein microarrays for theranostics and patient tailored therapy. Methods Mol Biol 2009; 520: 89-105 [PMID: 19381949 DOI: 10.1007/978- 1-60327-811-9-7]
28. Harlow E, Lane D. Antibodies: a laboratory manual. Cold Spring Harbor Laboratory, 1988: 449
29. Charafe-Jauffret E, Ginestier C, Monville F, Finetti P, Adélaïde J, Cervera N, Fekairi S, Xerri L, Jacquemier J, Birnbaum D, Bertucci F. Gene expression profiling of breast cell lines identifies potential new basal markers. Oncogene 2006; 25: 2273-2284 [[PMID: 16288205 DOI: 10.1038/sj.onc.1209254]
30. Boyd ZS, Wu QJ, O'Brien C, Spoerke J, Savage H, Fielder PJ, Amler L, Yan Y, Lackner MR. Proteomic analysis of breast cancer molecular subtypes and biomarkers of response to targeted kinase inhibitors using reverse-phase protein microarrays. Mol Cancer Ther 2008; 7: 3695-3706 [PMID: 19056674 DOI: 10.1158/1535-7163. MCT-08-0810]
31. Fumagalli F, Molteni R, Calabrese F, Frasca A, Racagni G, Riva MA. Chronic fluoxetine administration inhibits extracellular signal-regulated kinase 1/2 phosphorylation in rat brain. J Neurochem 2005; 93: 1551-1560 [PMID: 15935071 DOI: 10.1111/ j.1471-4159.2005.03149.x]
32. Tait L, Soule HD, Russo J. Ultrastructural and immunocytochemical characterization of an immortalized human breast epithelial cell line, MCF-10. Cancer Res 1990; 50: 6087-6094 [PMID: 1697506]
33. Kondo Y, Kondo S. Autophagy and cancer therapy. Autophagy 2006; 2: 85-90 [PMID: 16874083 DOI: 10.4161/auto.2.2.2463]
34. Gething MJ. Role and regulation of the ER chaperone BiP. Semin Cell Dev Biol 1999; 10: 465-472 [PMID: 10597629 DOI: 10.1006/ scdb.1999.0318]
35. Deng J, Lu PD, Zhang Y, Scheuner D, Kaufman RJ, Sonenberg N, Harding HP, Ron D. Translational repression mediates activation of nuclear factor kappa B by phosphorylated translation initiation factor 2. Mol Cell Biol 2004; 24: 10161-10168 [PMID: 15542827 DOI: 10.1128/MCB.24.23.10161-10168.2004]
36. Harding HP, Zhang Y, Bertolotti A, Zeng H, Ron D. Perk is essential for translational regulation and cell survival during the unfolded protein response. Mol Cell 2000; 5: 897-904 [PMID: 10882126 DOI: 10.1016/S1097-2765(00)80330-5]
37. Copetti T, Bertoli C, Dalla E, Demarchi F, Schneider C. p65/ RelA modulates BECN1 transcription and autophagy. Mol Cell Biol 2009; 29: 2594-2608 [PMID: 19289499 DOI: 10.1128/ MCB.01396-08]
38. Szegezdi E, Macdonald DC, Ní Chonghaile T, Gupta S, Samali A. Bcl-2 family on guard at the ER. Am J Physiol Cell Physiol 2009; 296: C941-C953 [PMID: 19279228 DOI: 10.1152/ ajpcell.00612.2008]
39. Nakagawa T, Yuan J. Cross-talk between two cysteine protease families. Activation of caspase-12 by calpain in apoptosis. J Cell Biol 2000; 150: 887-894 [PMID: 10953012 DOI: 10.1083/jcb.150.4.887]
40. Rao RV, Ellerby HM, Bredesen DE. Coupling endoplasmic reticulum stress to the cell death program. Cell Death Differ 2004; 11: 372-380 [PMID: 14765132 DOI: 10.1038/sj.cdd.4401378]
41. Rutkowski DT, Arnold SM, Miller CN, Wu J, Li J, Gunnison KM, Mori K, Sadighi Akha AA, Raden D, Kaufman RJ. Adaptation to ER stress is mediated by differential stabilities of pro-survival and pro-apoptotic mRNAs and proteins. PLoS Biol 2006; 4: e374 [PMID: 17090218 DOI: 10.1371/journal.pbio.0040374]
42. Brewer JW, Diehl JA. PERK mediates cell-cycle exit during the mammalian unfolded protein response. Proc Natl Acad Sci USA 2000; 97: 12625-12630 [PMID: 11035797 DOI: 10.1073/ pnas.220247197]
43. Sivaprasad U, Basu A. Inhibition of ERK attenuates autophagy and potentiates tumour necrosis factor-alpha-induced cell death in MCF-7 cells. J Cell Mol Med 2008; 12: 1265-1271 [PMID: 18266953 DOI: 10.1111/j.1582-4934.2008.00282.x]
44. Oh SH, Lim SC. Endoplasmic reticulum stress-mediated autophagy/apoptosis induced by capsaicin (8-methyl-N-vanillyl- 6-nonenamide) and dihydrocapsaicin is regulated by the extent of c-Jun NH2-terminal kinase/extracellular signal-regulated kinase activation in WI38 lung epithelial fibroblast cells. J Pharmacol Exp Ther 2009; 329: 112-122 [PMID: 19139269 DOI: 10.1124/ jpet.108.144113]
45. Cagnol S, Chambard JC. ERK and cell death: mechanisms of ERK-induced cell death-apoptosis, autophagy and senescence. FEBS J 2010; 277: 2-21 [PMID: 19843174 DOI: 10.1111/ j.1742-4658.2009.07366.x]
46. Goll DE, Thompson VF, Li H, Wei W, Cong J. The calpain system. Physiol Rev 2003; 83: 731-801 [PMID: 12843408 DOI: 10.1152/ physrev.00029.2002]
47. Lehmann BD, Bauer JA, Chen X, Sanders ME, Chakravarthy AB, Shyr Y, Pietenpol JA. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Invest 2011; 121: 2750-2767 [PMID: 21633166 DOI: 10.1172/JCI45014]
48. Navari RM, Brenner MC, Wilson MN. Treatment of depressive symptoms in patients with early stage breast cancer undergoing adjuvant therapy. Breast Cancer Res Treat 2008; 112: 197-201 [PMID: 18064563 DOI: 10.1007/s10549-007-9841-z]
49. Barbey JT, Roose SP. SSRI safety in overdose. J Clin Psychiatry 1998; 59 Suppl 15: 42-48 [PMID: 9786310]